Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia

Cancer

Volumn 110, Issue 7, 2007, Pages 1520-1526

  Konoplev, Sergej ^a   Medeiros, L Jeffrey ^a   Lennon, Patrick A ^a   Prajapati, Sapana ^a   Kanungo, Anuradha ^a   Lin, Pei ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Aplastic anemia; Growth factors; Monosomy 7; Myelodysplastic syndrome

Indexed keywords

CYCLOSPORIN; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 11; PREDNISONE; STEM CELL FACTOR; THYMOCYTE ANTIBODY;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BONE MARROW HYPOPLASIA; BONE MARROW TRANSPLANTATION; CELL GROWTH; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; HYPOPLASTIC MYELODYSPLASTIC SYNDROME; KARYOTYPE; MALE; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES;

ADULT; AGED; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CHROMOSOMES, HUMAN, PAIR 7; CYTOGENETIC ANALYSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMATOLOGIC TESTS; HUMANS; IMMUNOLOGIC FACTORS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MIDDLE AGED; MONOSOMY; MYELODYSPLASTIC SYNDROMES; RETROSPECTIVE STUDIES;

EID: 34648831219     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22935     Document Type: Article

References (36)

1. Linker CA. Blood. In: McPhee SJ, Papadakis MA, Tierney LM, editors. Current Medical Diagnosis and Treatment, 46th ed. New York, NY: Lange Medical Books/McGraw Hill; 2007;509-510, 518-519.
2. Kojima S, Ohara A, Tsuchida M, et al. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood. 2002;100:786-790.
3. Ohara A, Kojima S, Hamajima N, et al. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood. 1997;90:1009-1013.
4. Kaito K, Kobayashi M, Katayama T, et al. Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults. Br J Haematol. 1998;103:297-303.
5. Appelbaum FR, Barrall J, Storb R, et al. Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Exp Hematol. 1987;15:1134-1139.
6. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B. Late haematological complications in severe aplastic anaemia. Br J Haematol. 1988;69:413-418.
7. Knospe WH, Crosby WH. Aplastic anaemia: a disorder of the bone-marrow sinusoidal microcirculation rather than stem-cell failure? Lancet. 1971;1:20-22.
8. Sonoda Y, Ohno Y, Fujii H, et al. Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor). Stem Cells. 1993;11:543-554.
9. Imamura M, Kobayashi M, Kobayashi S, et al. Combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in aplastic anemia. Am J Hematol. 1995;48:29-33.
10. Bessho M, Jinnai I, Hirashima K, et al. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia. Stem Cells. 1994;12:604-615.
11. Antin JH, Smith BR, Holmes W, Rosenthal DS. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood. 1988;72:705-713.
12. Vadhan-Raj S, Buescher S, Broxmeyer HE, et al. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. N Engl J Med. 1988;319:1628-1634.
13. Guinan EC, Sieff CA, Oette DH, Nathan DG. A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia. Blood. 1990;76:1077-1082.
14. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108:2509-2519.
15. [No authors listed] Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study. Blood. 1987;70:1718-1721.
16. Oyarzo MP, Lin P, Glassman A, Bueso-Ramos CE, Luthra R, Medeiros LJ. Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations. Am J Clin Pathol. 2004;122:348-358.
17. Brunning RD, Bennett JM, Flandrin G, et al. Myelodysplastic syndromes. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:61-73.
18. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079-2088.
19. Schlette E, Rassidakis GZ, Canoz O, Medeiros LJ. Expression of bcl-3 in chronic lymphocytic leukemia correlates with trisomy 12 and abnormalities of chromosome 19. Am J Clin Pathol. 2005;123:465-471.
20. Talwalkar SS, Valbuena JR, Abruzzo LV et al. MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast. Mod Pathol. 2006;19:1402-1408.
21. Tuzuner N, Cox C, Rowe JM, Watrous D, Bennett JM. Hypocellular myelodysplastic syndromes (MDS): new proposals. Br J Haematol. 1995;91:612-617.
22. Maschek H, Kaloutsi V, Rodriguez-Kaiser M, et al. Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis. Ann Hematol. 1993;66:117-122.
23. Rosenfeld S, Follmann D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA. 2003;289:1130-1135.
24. Molldrem JJ, Caples M, Mavroudis D, Plante M, Young NS, Barrett AJ. Antithymocyte globulin for patients with myelodysplastic syndrome. Br J Haematol. 1997;99:699-705.
25. Maciejewski JP, Risitano A, Sloand EM, Nunez O, Young NS. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood. 2002;99:3129-3135.
26. Maciejewski JP, Selleri C. Evolution of clonal cytogenetic abnormalities in aplastic anemia. Leuk Lymphoma. 2004;45:433-440.
27. Fuhrer M, Burdach S, Ebell W, et al. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience.German/Austrian Pediatric Aplastic Anemia Working Group. Klin Padiatr. 1998;210:173-179.
28. de Planque MM, Kluin-Nelemans HC, van Krieken HJ, et al. Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. Br J Haematol. 1988;70:55-62.
29. Sloand EM, Yong AS, Ramkissoon S, et al. Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. Proc Natl Acad Sci USA. 2006;103:14483-14488.
30. Socie G, Mary JY, Schrezenmeier H, et al. Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT). Blood. 2007;109:2794-2796.
31. Socie G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia.European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 1993;329:1152-1157.
32. Socie G, Rosenfeld S, Frickhofen N, Gluckman E, Tichelli A. Late clonal diseases of treated aplastic anemia. Semin Hematol. 2000;37:91-101.
33. Barrett J, Saunthararajah Y, Molldrem J. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? Semin Hematol. 2000;37:15-29.
34. Kearns WG, Sutton JF, Maciejewski JP, Young NS, Liu JM. Genomic instability in bone marrow failure syndromes. Am J Hematol. 2004;76:220-224.
35. Keung YK, Pettenati MJ, Cruz JM, Powell BL, Woodruff RD, Buss DH. Bone marrow cytogenetic abnormalities of aplastic anemia. Am J Hematol. 2001;66:167-171.
36. Ohga S, Ohara A, Hibi S, et al. Treatment responses of childhood aplastic anaemia with chromosomal aberrations at diagnosis. Br J Haematol. 2002;118:313-319.